Raloxifene: Block Estrogen and Promote Muscle Growth with Dragon Pharmaceuticals

Raloxifene - Evista

Raloxifene by Dragon Pharma contains Raloxifene Hydrochloride, a potent SERM delivered in 100 tablets at 60 mg each. Widely used for gynecomastia prevention and bone health, it's a key tool for bodybuilders managing estrogenic side effects from anabolic steroids and for individuals seeking to maintain bone density. With a half-life of approximately 27–28 hours, Raloxifene provides steady effects with daily dosing, supporting a balanced, healthy physique.

What It Is

Raloxifene Hydrochloride, marketed as Evista, is a second-generation SERM originally developed for treating osteoporosis and breast cancer in postmenopausal women. In bodybuilding, it's used off-label to block estrogen receptors in breast tissue, preventing gynecomastia, and to support testosterone production during post-cycle therapy (PCT). Its selective action minimizes estrogenic effects while promoting bone health and lipid profiles, making it a safer alternative to aromatase inhibitors in some cases.

How It Works

Raloxifene binds to estrogen receptors, acting as an antagonist in breast tissue to prevent gynecomastia and as an agonist in bone tissue to enhance density. It stimulates luteinizing hormone (LH) and follicle-stimulating hormone (FSH), supporting natural testosterone production during PCT. Unlike aromatase inhibitors, it doesn't drastically lower systemic estrogen levels, preserving beneficial estrogen effects on lipids and bones. Its detection time is approximately 1–2 months in drug tests.

Benefits

• Gynocomastia Prevention: Blocks estrogen in breast tissue to prevent or reduce gyno.
• Testosterone Support: Stimulates LH and FSH for hormonal recovery in PCT.
• Bone Health: Increases bone density, reducing fracture risk during heavy lifting.
• Lipid Profile Support: Improves cholesterol levels compared to aromatase inhibitors.
• Mild Profile: Minimal impact on systemic estrogen, reducing side effects.

Who It's For

Raloxifene is ideal for male bodybuilders aged 21–40 using aromatizing steroids (e.g., testosterone, Dianabol) to prevent gynecomastia or for PCT to restore testosterone levels. It's suitable for intermediate to advanced users. Not for: Women (unless prescribed for osteoporosis or breast cancer), individuals under 21, or those with clotting disorders. Medical supervision and regular blood work are essential.

How to Use

Dosage: Typical dosage for men in bodybuilding is 30–60 mg/day (0.5–1 tablet) for gynecomastia prevention or PCT. Women, if prescribed, use 60 mg/day under medical guidance for osteoporosis or breast cancer.

Administration: Take orally with water, with or without food. For PCT, start 1–2 weeks after the last steroid injection (or 1–2 days for short-acting compounds). Administer at the same time daily for stable blood levels. Use for 4–6 weeks in PCT or throughout a steroid cycle for estrogen control.

Results Timeline: Gynecomastia reduction and testosterone recovery begin within 1–2 weeks, with full hormonal restoration by 4–6 weeks when combined with proper PCT protocols.

Stacking Suggestions

Raloxifene is typically used for support in cycles or PCT:

• PCT Stack: Combine with Clomid (25–50 mg/day) and HCG (500–1000 IU EOD) for 4–6 weeks to enhance testosterone recovery.
• On-Cycle Support: Pair with Testosterone Enanthate (250–750 mg/week) to prevent gynecomastia.
• Support: Use with fish oil (2–4 g/day) to support lipid health.

Side Effects

Raloxifene is generally well-tolerated but may cause:

• Common: Hot flashes, leg cramps, or mild fatigue.
• Rare: Increased risk of blood clots (e.g., deep vein thrombosis); monitor for symptoms.
• Other: Mild joint pain or flu-like symptoms in some users.
• Hepatotoxicity: Minimal, but monitor liver function with prolonged use.

Regular blood work to monitor hormones, lipids, and clotting factors is recommended.

Post Cycle Therapy (PCT)

Raloxifene is a key PCT component, typically used at 30–60 mg/day for 4–6 weeks to restore testosterone production. Combine with Clomid (25–50 mg/day) and HCG (500–1000 IU EOD for the first 2 weeks) for optimal hypothalamic-pituitary-gonadal (HPG) axis recovery. Start PCT based on the half-life of the steroids used. Monitor testosterone, LH, and FSH levels via blood work.